Skip to content

Clinical trials

Observational Breast Neoplasms trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Observational Status: Unknown status Clear all

586 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20041
200511
20067
200710
200811
200911
201022
201118
201221
201315
201431
201526
201626
201720
201837
201957
202045
202172
202245
202354
202437

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status586

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University30
Fudan University15
National University Hospital, Singapore13
European Institute of Oncology12
National Taiwan University Hospital12
Assistance Publique - Hôpitaux de Paris9
Peking Union Medical College Hospital9
Peking University People's Hospital9
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University9
Tianjin Medical University Cancer Institute and Hospital8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms586
Neoplasms27
Lung Neoplasms18
Prostatic Neoplasms18
Ovarian Neoplasms17
Colonic Neoplasms14
Neoplasm Metastasis14
Triple Negative Breast Neoplasms14
Colorectal Neoplasms13
Pancreatic Neoplasms13

Trials

Showing 1 to 25 of 586. Each trial links to its page on Pharma Observatory.

486 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.